Your browser doesn't support javascript.
loading
Influence of Intermittent Hypoxia/Hypercapnia on Atherosclerosis, Gut Microbiome, and Metabolome.
Xue, Jin; Allaband, Celeste; Zhou, Dan; Poulsen, Orit; Martino, Cameron; Jiang, Lingjing; Tripathi, Anupriya; Elijah, Emmanuel; Dorrestein, Pieter C; Knight, Rob; Zarrinpar, Amir; Haddad, Gabriel G.
Afiliação
  • Xue J; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Allaband C; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Zhou D; Biomedical Sciences Program, University of California, San Diego, San Diego, CA, United States.
  • Poulsen O; Division of Gastroenterology, University of California, San Diego, San Diego, CA, United States.
  • Martino C; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Jiang L; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Tripathi A; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Elijah E; Bioinformatics and Systems Biology Program, University of California, San Diego, San Diego, CA, United States.
  • Dorrestein PC; Center for Microbiome Innovation, University of California, San Diego, San Diego, CA, United States.
  • Knight R; Division of Biostatistics, University of California, San Diego, San Diego, CA, United States.
  • Zarrinpar A; Department of Pediatrics, University of California, San Diego, San Diego, CA, United States.
  • Haddad GG; Division of Biological Sciences, University of California, San Diego, San Diego, CA, United States.
Front Physiol ; 12: 663950, 2021.
Article em En | MEDLINE | ID: mdl-33897472
ABSTRACT
Obstructive sleep apnea (OSA), a common sleep disorder characterized by intermittent hypoxia and hypercapnia (IHC), increases atherosclerosis risk. However, the contribution of intermittent hypoxia (IH) or intermittent hypercapnia (IC) in promoting atherosclerosis remains unclear. Since gut microbiota and metabolites have been implicated in atherosclerosis, we examined whether IH or IC alters the microbiome and metabolome to induce a pro-atherosclerotic state. Apolipoprotein E deficient mice (ApoE-/- ), treated with IH or IC on a high-fat diet (HFD) for 10 weeks, were compared to Air controls. Atherosclerotic lesions were examined, gut microbiome was profiled using 16S rRNA gene amplicon sequencing and metabolome was assessed by untargeted mass spectrometry. In the aorta, IC-induced atherosclerosis was significantly greater than IH and Air controls (aorta, IC 11.1 ± 0.7% vs. IH 7.6 ± 0.4%, p < 0.05 vs. Air 8.1 ± 0.8%, p < 0.05). In the pulmonary artery (PA), however, IH, IC, and Air were significantly different from each other in atherosclerotic formation with the largest lesion observed under IH (PA, IH 40.9 ± 2.0% vs. IC 20.1 ± 2.6% vs. Air 12.2 ± 1.5%, p < 0.05). The most differentially abundant microbial families (p < 0.001) were Peptostreptococcaceae, Ruminococcaceae, and Erysipelotrichaceae. The most differentially abundant metabolites (p < 0.001) were tauro-ß-muricholic acid, ursodeoxycholic acid, and lysophosphoethanolamine (180). We conclude that IH and IC (a) modulate atherosclerosis progression differently in distinct vascular beds with IC, unlike IH, facilitating atherosclerosis in both aorta and PA and (b) promote an atherosclerotic luminal gut environment that is more evident in IH than IC. We speculate that the resulting changes in the gut metabolome and microbiome interact differently with distinct vascular beds.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos